Net (loss) income from continuing operations attributable to Amedisys, Inc.

Add:

Provision for income taxes

Interest expense, net

Depreciation and amortization

EBITDA (1)

Add:

Certain items (2)

Intangible write-off (2)

Adjusted EBITDA (3)

Adjusted Net Service Revenue Reconciliation

Net service revenue

Add:

Certain items (2)

Adjusted net service revenue (4)

Adjusted Net Income From Continuing Operations Attributable to Amedisys, Inc. per Diluted Share:

Net (loss) income from continuing operations attributable to Amedisys, Inc. common stockholders per diluted share

Add:

Certain items (2)

Adjusted net income from continuing operations attributable to Amedisys, Inc. common stockholders per diluted share (5)

EBITDA is defined as net (loss) income from continuing operations attributable to Amedisys, Inc. before provision for income taxes, net interest expense, and depreciation and amortization. EBITDA should not be considered as an alternative to, or more meaningful than, income before income taxes, cash flow from operating activities, or other traditional indicators of operating performance. This calculation of EBITDA may not be comparable to a similarly titled measure reported by other companies, since not all companies calculate this non-GAAP financial measure in the same manner.

During the year ended December 31, 2011, we recorded charges for the impairment of goodwill and other intangibles and incurred certain costs associated with acquisitions and related integrations costs and legal expenses related to the United States Senate Committee on Finance inquiry and the SEC and Department of Justice investigations. We also incurred costs associated with our exit activities for those care centers which were consolidated or for which the startup process was discontinued during 2011, which includes $0.7 million for the write-off of intangibles. For the year ended December 31, 2011, these charges were offset, in part, by the release of a valuation allowance related to specific deferred tax assets and a Centers for Medicare and Medicaid Services (“CMS”) bonus payment as the result of the pay for performance demonstration. The following details these items (amounts in thousands, except per share data):

CMS Bonus

Goodwill and other intangibles impairment charge

Valuation allowance adjustment

Exit activities related to continuing operations

Certain costs

Total

Georgia indigent care liability

CMS Bonus

Exit activities related to continuing operations

Certain costs

Total

Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. from continuing operations before provision for income taxes, net interest expense, depreciation and amortization plus certain items as described in footnote 2. Adjusted EBITDA should not be considered as an alternative to, or more meaningful than, income before income taxes, cash flow from operating activities, or other traditional indicators of operating performance. This calculation of adjusted EBITDA may not be comparable to a similarly titled measure reported by other companies, since not all companies calculate this non-GAAP financial measure in the same manner.

Adjusted net service revenue is defined as net service revenue plus certain items as described in footnote 2. Adjusted net service revenue should not be considered as an alternative to, or more meaningful than, income before income taxes, cash flow from operating activities, or other traditional indicators of operating performance. This calculation of adjusted net service revenue may not be comparable to a similarly titled measure reported by other companies, since not all companies calculate this non-GAAP measure in the same manner.

Adjusted net income from continuing operations attributable to Amedisys, Inc. common stockholders per diluted share is defined as diluted (loss) earnings from continuing operations per share plus the earnings per share effect of certain items as described in footnote 2. Adjusted net income from continuing operations attributable to Amedisys, Inc. common stockholders per diluted share should not be considered as an alternative to, or more meaningful than, income before income taxes, cash flow from operating activities, or other traditional indicators of operating performance. This calculation of adjusted net income from continuing operations attributable to Amedisys, Inc. common stockholders per diluted share may not be comparable to a similarly titled measure reported by other companies, since not all companies calculate this non-GAAP financial measure in the same manner.